318 related articles for article (PubMed ID: 12087132)
1. Vascular growth factors and lymphangiogenesis.
Jussila L; Alitalo K
Physiol Rev; 2002 Jul; 82(3):673-700. PubMed ID: 12087132
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA; Paavonen K
Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms and role of lymphangiogenesis in cancer metastasis].
Dupuy E; Tobelem G
Bull Cancer; 2003 Jul; 90(7):595-9. PubMed ID: 12957800
[TBL] [Abstract][Full Text] [Related]
4. Molecular control of lymphangiogenesis.
Baldwin ME; Stacker SA; Achen MG
Bioessays; 2002 Nov; 24(11):1030-40. PubMed ID: 12386934
[TBL] [Abstract][Full Text] [Related]
5. [Lymphangiogenesis and biological activity ov vascular endothelial growth factor-C].
Mandriota SJ; Pepper MS
J Soc Biol; 1999; 193(2):159-63. PubMed ID: 10451350
[TBL] [Abstract][Full Text] [Related]
6. The role of tumor lymphangiogenesis in metastatic spread.
Stacker SA; Baldwin ME; Achen MG
FASEB J; 2002 Jul; 16(9):922-34. PubMed ID: 12087053
[TBL] [Abstract][Full Text] [Related]
7. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
8. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
Krishnan J; Kirkin V; Steffen A; Hegen M; Weih D; Tomarev S; Wilting J; Sleeman JP
Cancer Res; 2003 Feb; 63(3):713-22. PubMed ID: 12566318
[TBL] [Abstract][Full Text] [Related]
9. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
[TBL] [Abstract][Full Text] [Related]
10. Lymphangiogenesis, inflammation and metastasis.
Schoppmann SF
Anticancer Res; 2005; 25(6C):4503-11. PubMed ID: 16334134
[TBL] [Abstract][Full Text] [Related]
11. [Characterization of markers and growth factors for lymphatic endothelium].
Waś H
Postepy Biochem; 2005; 51(2):209-14. PubMed ID: 16209358
[TBL] [Abstract][Full Text] [Related]
12. Development of the lymphatic vascular system: a mystery unravels.
Hong YK; Shin JW; Detmar M
Dev Dyn; 2004 Nov; 231(3):462-73. PubMed ID: 15376314
[TBL] [Abstract][Full Text] [Related]
13. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin.
Dafni H; Israely T; Bhujwalla ZM; Benjamin LE; Neeman M
Cancer Res; 2002 Nov; 62(22):6731-9. PubMed ID: 12438274
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis.
Björndahl MA; Cao R; Burton JB; Brakenhielm E; Religa P; Galter D; Wu L; Cao Y
Cancer Res; 2005 Oct; 65(20):9261-8. PubMed ID: 16230387
[TBL] [Abstract][Full Text] [Related]
16. New insights into the biology and pathology of the cutaneous lymphatic system.
Hirakawa S; Detmar M
J Dermatol Sci; 2004 Jun; 35(1):1-8. PubMed ID: 15194141
[TBL] [Abstract][Full Text] [Related]
17. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D.
McColl BK; Baldwin ME; Roufail S; Freeman C; Moritz RL; Simpson RJ; Alitalo K; Stacker SA; Achen MG
J Exp Med; 2003 Sep; 198(6):863-8. PubMed ID: 12963694
[TBL] [Abstract][Full Text] [Related]
18. [The biology of lymphatic vessels - new findings ].
Jussila L; Alitalo K; Kaipainen A
Duodecim; 1998; 114(4):343-8. PubMed ID: 11466946
[No Abstract] [Full Text] [Related]
19. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
20. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins.
Tammela T; He Y; Lyytikkä J; Jeltsch M; Markkanen J; Pajusola K; Ylä-Herttuala S; Alitalo K
Circ Res; 2007 May; 100(10):1468-75. PubMed ID: 17478733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]